Rac3-Mediated Transformation Requires Multiple Effector Pathways
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Our initial characterization of Rac3, a close relative of the small GTPase Rac1, established its ability to promote membrane ruffling, transformation, and activation of c-jun transcriptional activity. The finding that Rac3 is transforming, and its similarity to Rac1, a protein that has a well-established connection to many processes important for cancer progression, prompted further investigation into Rac3 transformation. We used effector domain mutants (EDMs) to explore the relationship among Rac signaling, transformation, and effector usage. All Rac3 EDMs tested (N26D, F37L, Y40C, and N43D) retained the ability to promote membrane ruffling and focus formation. In contrast, only the N43D mutant promoted anchorage independence. This differs from Rac1, where both N26D and N43D mutants were impaired in both types of transformation. To learn more about the signaling pathways involved, we did luciferase reporter assays and glutathione S-transferase pull-down assays for effector binding. We found evidence for a functional link between activation of phospholipase Cβ2 by Rac3 and signaling to the serum response factor (SRF). Surprisingly, we also found that Rac3 binds poorly to the known Rac1 effectors mixed lineage kinases 2 and 3 (MLK2 and MLK3). Transcription of cyclin D1 was the only pathway that correlated with growth in soft agar. Our experiments show that activation of membrane ruffling and transcriptional activation of c-jun, SRF, or E2F are not sufficient to promote anchorage-independent growth mediated by Rac3. Instead, multiple effector pathways are required for Rac3 transformation, and these overlap partially but not completely with those used by Rac1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rational design and characterization of a Rac GTPase-specific small molecule inhibitor
Gao, Y., Dickerson, J. B., Guo, F., Zheng, J., & Zheng, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307512101 · Cited by 1,091 · cited 1×
“Given these activities, Rac1 has become a target for inhibitors that may be useful in future cancer therapies (16, 17 ).”
BackgroundSpecific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934 · cited 9×
“Rac1 is one of the most heavily studied members of the Rho subfamily of Ras-related small GTPases (1).”
BackgroundInfluentialActivation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation
Khosravi-Far, R., Solski, P. A., Clark, G. J., Kinch, M. S., & Der, C. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.11.6443 · Cited by 683 · cited 9×
“Rac1 is one of the most heavily studied members of the Rho subfamily of Ras-related small GTPases (1).”
BackgroundInfluentialCharacterization of RAC3, a Novel Member of the Rho Family
Haataja, L., Groffen, J., & Heisterkamp, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20384 · Cited by 243 · cited 6×
“differences occurring in the COOH-terminal membrane targeting region and in regions surrounding and within the Rho insert domain (18, 19).”
BackgroundInfluentialBuchsbaum, R. J., Connolly, B. A., & Feig, L. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4073-4085.2002 · Cited by 198
Cited by
Pai, S.-Y., Kim, C., & Williams, D. A. (2010) · Disease Markers · doi:10.1155/2010/380291 · Cited by 85
Bunney, T. D., Opaleye, O., Roe, S. M., Vatter, P., Baxendale, R. W., Walliser, C., Everett, K. L., Josephs, M. B., Christow, C., Rodrigues-Lima, F., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.02.023 · Cited by 72
“For PLCb2, this has already been illustrated to be a useful tool in delineating the role of Rac3 in activating different downstream effector pathways (Keller et al., 2005).”
MethodRho GTPases and Regulation of Hematopoietic Stem Cell Localization
(2008) · Methods in Enzymology · doi:10.1016/s0076-6879(07)00427-2 · Cited by 54
Rozenveld-Geugien, M., Baas, I. O., van Gosliga, D., Vellenga, E., & Schuringa, J. J. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.02.006 · Cited by 19
Metadata
- Authors
- Keller, P. J., Gable, C. M., Wing, M. R., & Cox, A. D.
- Venue
- Cancer Research
- Published
- 2005-11-01
- Volume
- 65
- Issue
- 21
- Pages
- 9883-9890
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2103188253
- Cited by
- 15
- References
- 5
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rac3-Mediated Transformation Requires Multiple Effector Pathways. https://app.cochat.ai/papers/10.1158/0008-5472.can-04-3116
- The paper
- Keller, P. J., Gable, C. M., Wing, M. R., & Cox, A. D. (2005). Rac3-Mediated Transformation Requires Multiple Effector Pathways. Cancer Research. https://doi.org/10.1158/0008-5472.can-04-3116
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.